X
X
Total 667546 Results
| Label | Description | ILX | Version | Created CID | Modified Time | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BDNF | ILX:0101140 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Beam Description | User-defined description for Beam. | ILX:0101141 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Dose | Dose (in Gy) at Beam Dose Specification Point (300A,0082) due to current Beam for one treatment fraction. | ILX:0101142 | 7 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Beam Dose Specification Point | Coordinates (x,y,z) of point at which Beam Dose is specified in the patient based coordinate system described in mm. | ILX:0101143 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Limiting Device Angle | Beam Limiting Device (collimator) angle, i.e., orientation of IEC BEAM LIMITING DEVICE coordinate system with respect to IEC GANTRY coordinate system (degrees). | ILX:0101144 | 6 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Beam Limiting Device Angle Tolerance | Maximum permitted difference (in degrees) between planned and delivered Beam Limiting Device Angle. | ILX:0101145 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Limiting Device Leaf Pairs Sequence | Introduces sequence of beam limiting device (collimator) jaw or leaf (element) leaf pair values. The sequence may contain one or more items. | ILX:0101146 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Limiting Device Position Sequence | Sequence of beam limiting device (collimator) jaw or leaf (element) positions. | ILX:0101147 | 5 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Beam Limiting Device Position Tolerance | Maximum permitted difference (in mm) between planned and delivered leaf (element) or jaw positions for current beam limiting device (collimator). | ILX:0101148 | 7 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Beam Limiting Device Rotation Direction | Direction of Beam Limiting Device Rotation when viewing beam limiting device (collimator) from radiation source, for segment following Control Point. Required for first item of Control Point Sequence, or if Beam Limiting Device Rotation Direction changes. | ILX:0101149 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Limiting Device Sequence | Sequence of beam limiting device (collimator) jaw or leaf (element) positions for given exposure. | ILX:0101150 | 6 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Beam Limiting Device Tolerance Sequence | Sequence of beam limiting device (collimator) tolerances. | ILX:0101151 | 6 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Beam Meterset | Machine setting to be delivered for current Beam, specified in Monitor Units (MU) or minutes as defined by Primary Dosimeter Unit (300A,00B3) (in ) for referenced Beam. | ILX:0101152 | 5 | scicrunch | 08/28/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Beam Name | User-defined name for Beam. | ILX:0101153 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Number | Identification number of the Beam. The value of Beam Number (300A,00C0) shall be unique within the RT Plan in which it is created. | ILX:0101154 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Sequence | Introduces sequence of treatment beams for current RT Plan. One or more items may be included in this sequence. | ILX:0101155 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Stopper Position | Position of Beam Stopper during beam administration. | ILX:0101156 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Type | Motion characteristic of Beam. | ILX:0101157 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beat Rejection Flag | Beat length sorting has been applied. | ILX:0101158 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Becaplermin | Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin has a molecular weight of approximately 25 KD and is a homodimer composed of two identical polypeptide chains that are bound together by disulfide bonds Pharmacology: Used for the topical treatment of skin ulcers, Regranex has a biological activity similar to that of endogenous platelet-derived growth factor, which includes promoting the chemotactic recruitment and proliferation of cells involved in wound repair and enhancing the formation of granulation tissue. Mechanism of action: Binds to the beta platelet-derived growth factor (PDGF) receptor, a tyrosine kinase receptor. PDGF is known to exist as a dimer, and activates its signaling pathway by a ligand induced receptor dimerization and autophosphorylation. PDGF receptors also contain many auto-phosphorylation sites, which serve to mediate binding of SH2 sites and subsequently signal corresponding pathways. There are five different isoforms of PDGF that activate through two different receptors (alpha and beta). Drug type: Approved. Biotech. Investigational. Drug category: Anti-Ulcer Agents. Topical | ILX:0101159 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
About
Base community for the SciCrunch.org infrastructure
Contact Us
X